AGEN : Summary for Agenus Inc. - Yahoo Finance

U.S. Markets closed

Agenus Inc. (AGEN)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.88-0.04 (-1.02%)
At close: 4:00PM EDT
People also watch
CTICARRYCRISEXELARIA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.92
Open3.94
Bid3.88 x 100
Ask3.97 x 1500
Day's Range3.87 - 3.97
52 Week Range2.97 - 7.49
Volume661,740
Avg. Volume1,183,393
Market Cap381.51M
Beta2.59
PE Ratio (TTM)-2.66
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    Agenus to Participate at Two Upcoming Immuno-Oncology Conferences

    LEXINGTON, Mass., March 24, 2017 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced participation ...

  • Agenus, Inc. :AGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube5 days ago

    Agenus, Inc. :AGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis Agenus, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Agenus, Inc. – Idera Pharmaceuticals, Inc., Cascadian Therapeutics Inc., GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc., Johnson & Johnson, ImmunoCellular Therapeutics, Ltd., Bristol-Myers Squibb Company and Celldex Therapeutics, ... Read more (Read more...)

  • 4 Biotech Stocks With Jaw-Dropping Growth Potential
    Motley Fool5 days ago

    4 Biotech Stocks With Jaw-Dropping Growth Potential

    These biotechs are poised to surge higher in the years ahead.